Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor ActivityJonathan D. Graves, Pamela M. Holland, Xiaoning Zhao et al.|Cancer Cell|2014Cited by 155
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Javier Chaparro‐Riggers, Martin E. van Royen et al.|Cancer Immunology Research|2021Cited by 98